Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease

Veneracion G. Cabana*, Samuel S. Gidding, Godfrey S. Getz, Jennifer Chapman, Stanford T. Shulman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


In this study we report changes in HDL concentration and composition in acute and convalescent Kawasaki disease. Notable reductions in plasma HDL- cholesterol (0.54 ± 0.2 mmol/L, normal level 0.7-1.81 mmol/L) and apolipoprotein A-I (apoA-I) (56 ± 28 mg/dL, normal level 141 ± 22 mg/dL) were observed in all 24 patients studied during the acute phase of Kawasaki disease. These changes were accompanied by the marked appearance of serum amyloid A (SAA) protein in the plasma, associated with HDL3 like lipoprotein particles. The distribution of apoA-I was analyzed in five patients and showed a significant increase in lipid-free apoA-I in the bottom fraction (28.8 ± 4.1%, normal range 10-15%), suggesting displacement of apoA-I from the HDL particles by SAA. Within 2 wk after acute kawasaki disease, levels of HDL-cholesterol and apoA-I returned to the normal range, and SAA disappeared from the plasma. The HDL of patients with Kawasaki disease was markedly enriched in triglyceride even in the absence of changes in total plasma triglyceride. The core composition of HDL returned to the normal range more slowly than the plasma HDL-cholesterol and apoA-I levels. This suggests that Kawasaki disease has a profound effect on the lipoprotein profile acutely and a more subtle sustained effect on the HDL composition. We interpret these changes as manifestations of the acute phase response in Kawasaki disease.

Original languageEnglish (US)
Pages (from-to)651-655
Number of pages5
JournalPediatric research
Issue number5
StatePublished - Nov 1997

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease'. Together they form a unique fingerprint.

Cite this